{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:48:58Z","timestamp":1782125338465,"version":"3.54.5"},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.athoracsur.2026.03.074","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:01:38Z","timestamp":1776700898000},"page":"3-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1405-8487","authenticated-orcid":false,"given":"Jeffrey B.","family":"Velotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja C.","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bansari","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Taylor","family":"Ripley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedy L.","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W. Awori","family":"Hayanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2026.03.074_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jtho.2024.12.014","article-title":"A perspective on the MARS2 Trial","volume":"20","author":"Lim","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib2","first-page":"420","article-title":"The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review","volume":"106","author":"Eriksen","year":"2018","journal-title":"Med Libr Assoc"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.athoracsur.2024.09.023","volume":"119","author":"Milojevic","year":"2025","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-025-00640-3","article-title":"Pleural mesothelioma","volume":"11","author":"Fennell","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib7","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3390\/cancers17172786","article-title":"Malignant local seeding in procedure tracts of pleural mesothelioma: incidence and novel risk factors in 308 patients","volume":"17","author":"Lapidot","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib8","first-page":"4164","article-title":"Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma","volume":"125","author":"Chirieac","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib9","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/arpa.2023-0304-RA","article-title":"Guidelines for pathologic diagnosis of mesothelioma: 2023 update of the consensus statement from the international mesothelioma interest group","volume":"148","author":"Husain","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jtcvs.2006.03.068","article-title":"Positron emission tomography predicts survival in malignant pleural mesothelioma","volume":"132","author":"Flores","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1053\/j.semnuclmed.2022.04.011","article-title":"FDG PET\/CT for primary staging of lung cancer and mesothelioma","volume":"52","author":"Kandathil","year":"2022","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/j.semnuclmed.2022.07.005","article-title":"FDG PET\/CT for staging and restaging malignant mesothelioma","volume":"52","author":"Lopci","year":"2022","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib13","article-title":"Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET\/CT scan in patients with malignant pleural mesothelioma","volume":"15","author":"Lim","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13550-020-00669-3","article-title":"FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients","volume":"10","author":"Pavic","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/jcm11010033","article-title":"The prognostic value of (18)F-FDG PET imaging at staging in patients with malignant pleural mesothelioma: a literature review","volume":"11","author":"Taralli","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12935-022-02482-5","article-title":"Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET\/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis","volume":"22","author":"Wen","year":"2022","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ejcts.2003.12.001","article-title":"The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma","volume":"25","author":"Pilling","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ejcts\/ezr251","article-title":"The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma","volume":"42","author":"Nakas","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib19","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1158\/1078-0432.CCR-07-5283","article-title":"Transesophageal endoscopic ultrasound with fine needle aspiration in the preoperative staging of malignant pleural mesothelioma","volume":"14","author":"Tournoy","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/dc.20740","article-title":"Endoscopic ultrasound-guided fine needle aspiration is useful for nodal staging in patients with pleural mesothelioma","volume":"36","author":"Bean","year":"2008","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.21037\/jtd.2019.01.01","article-title":"Endobronchial ultrasound-guided transbronchial needle aspiration mediastinal lymph node staging in malignant pleural mesothelioma","volume":"11","author":"Czarnecka-Kujawa","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF02305768","article-title":"Laparoscopy: an important tool in the staging of malignant pleural mesothelioma","volume":"3","author":"Conlon","year":"1996","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib23","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.athoracsur.2020.08.113","article-title":"Diagnostic laparoscopy improves staging of malignant pleural mesothelioma with routine positron emission tomography imaging","volume":"112","author":"Ripley","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib24","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jtho.2023.08.005","article-title":"The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: updated modeling of prognostic factors in pleural mesothelioma","volume":"18","author":"Wolf","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jtho.2019.08.2506","article-title":"EURACAN\/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach","volume":"15","author":"Nicholson","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib27","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cllc.2022.09.003","article-title":"Comparison of survival by multimodal treatment regimen among malignant pleural mesothelioma patients in an integrated health system","volume":"23","author":"Banks","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012092","article-title":"What is the role of a specialist regional mesothelioma multidisciplinary team meeting? A service evaluation of one tertiary referral centre in the UK","volume":"6","author":"Bibby","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-2600(24)00119-X","article-title":"Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial","volume":"12","author":"Lim","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib30","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.semtcvs.2024.07.001","article-title":"Should treatment of mesothelioma include surgery? MARS2 fails to land","volume":"38","author":"Gulati","year":"2026","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib32","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jtcvs.2024.12.006","article-title":"Going to MARS may shorten our patient's survival","volume":"169","author":"Ripley","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ejcts\/ezaa158","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"58","author":"Opitz","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib34","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1200\/JCO-24-02425","article-title":"Treatment of pleural mesothelioma: ASCO guideline update","volume":"43","author":"Kindler","year":"2025","journal-title":"J Clin Oncol"},{"issue":"suppl 2","key":"10.1016\/j.athoracsur.2026.03.074_bib35","first-page":"S238","article-title":"Management of malignant pleural mesothelioma\u2014the European experience","volume":"6","author":"Opitz","year":"2014","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib36","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jtho.2018.08.001","article-title":"Surgery in malignant pleural mesothelioma","volume":"13","author":"Bueno","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib37","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1245\/s10434-021-09589-5","article-title":"Landmark trials in the surgical management of mesothelioma","volume":"28","author":"Kantor","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"suppl 2","key":"10.1016\/j.athoracsur.2026.03.074_bib38","doi-asserted-by":"crossref","first-page":"S285","DOI":"10.21037\/jtd.2017.10.16","article-title":"Surgery for malignant pleural mesothelioma: an international guidelines review","volume":"10","author":"Ricciardi","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib39","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.21037\/jtd-22-427","article-title":"Improving outcomes in malignant pleural mesothelioma in an integrated health care system","volume":"14","author":"Ossowski","year":"2022","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s005950300000","article-title":"Postoperative complications of pulmonary resection after platinum-based induction chemotherapy for primary lung cancer","volume":"33","author":"Muraoka","year":"2003","journal-title":"Surg Today"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jtcvs.2014.03.011","article-title":"Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality","volume":"148","author":"Burt","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5761\/atcs.oa.09.01427","article-title":"Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients","volume":"17","author":"Bagheri","year":"2011","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib43","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thorax.55.9.731","article-title":"Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems","volume":"55","author":"Edwards","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib44","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/annonc\/mdy195","article-title":"Pleural mesothelioma: is the surgeon still there?","volume":"29","author":"Opitz","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib45","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.21037\/jtd.2016.07.55","article-title":"Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma","volume":"8","author":"Sandri","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib46","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/cancers16091719","article-title":"The role of surgery in pleural mesothelioma","volume":"16","author":"Lapidot","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejcts.2007.09.044","article-title":"Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients","volume":"33","author":"Borasio","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib48","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/cancers17142360","article-title":"Effectiveness of surgical treatment on survival of patients with malignant pleural mesothelioma","volume":"17","author":"B\u00e1ez-Salda\u00f1a","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib49","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijsu.2008.04.004","article-title":"Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma","volume":"6","author":"Neragi-Miandoab","year":"2008","journal-title":"Int J Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib52","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B","volume":"113","author":"Herndon","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib53","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/modpathol.2017.170","article-title":"Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study","volume":"31","author":"Rosen","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/his.15065","article-title":"Updates on grading mesothelioma","volume":"84","author":"Schulte","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib55","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jtho.2024.05.003","article-title":"The International Association for the Study of Lung Cancer Mesothelioma Staging Project: proposals for the \"N\" descriptors in the forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma","volume":"19","author":"Bille","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib56","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.athoracsur.2009.05.022","article-title":"Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma","volume":"88","author":"Rice","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib57","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1067\/mtc.2001.116560","article-title":"A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"122","author":"Rusch","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the \"SMART\" approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01243894-200605000-00004","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial","volume":"1","author":"Flores","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib60","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jtcvs.2018.10.039","article-title":"Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resection","volume":"157","author":"Verma","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib61","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/jnci\/djaa002","article-title":"The role of neoadjuvant chemotherapy in patients with resectable malignant pleural mesothelioma\u2014an institutional and national analysis","volume":"112","author":"Voigt","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib62","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02114-2023","article-title":"A randomised phase II study of extended pleurectomy\/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205","volume":"63","author":"Raskin","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70024","article-title":"Impact of neoadjuvant and adjuvant pleural intensity-modulated radiotherapy in multimodality treatment for malignant pleural mesothelioma","volume":"16","author":"Mosleh","year":"2025","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib64","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1038\/s41591-025-03958-3","article-title":"Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses","volume":"31","author":"Reuss","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thx.31.1.15","article-title":"Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients","volume":"31","author":"Butchart","year":"1976","journal-title":"Thorax"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5223(19)36577-8","article-title":"The role of extrapleural pneumonectomy in malignant pleural mesothelioma: a Lung Cancer Study Group trial","volume":"102","author":"Rusch","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib67","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5223(96)70342-2","article-title":"The importance of surgical staging in the treatment of malignant pleural mesothelioma","volume":"111","author":"Rusch","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib69","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0003-4975(99)01038-3","article-title":"Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically","volume":"68","author":"Rusch","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib70","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib71","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib72","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the International Association for the Study of Lung Cancer Mesothelioma Database","volume":"7","author":"Rusch","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib73","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib74","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jtcvs.2008.02.069","article-title":"The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system","volume":"136","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jtcvs.2006.06.044","article-title":"Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"133","author":"de Perrot","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib76","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejcts.2007.01.064","article-title":"Case-control study between extrapleural pneumonectomy and radical pleurectomy\/decortication for pathological N2 malignant pleural mesothelioma","volume":"31","author":"Martin-Ucar","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib77","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/j.cllc.2020.01.002","article-title":"Impact of detecting occult pathologic nodal disease during resection for malignant pleural mesothelioma","volume":"21","author":"Verma","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib78","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.3390\/jcm10215177","article-title":"Malignant pleural mesothelioma nodal status: where are we at?","volume":"10","author":"Ricciardi","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib79","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.jtho.2016.09.121","article-title":"The IASLC Mesothelioma Staging Project: proposals for revisions of the N descriptors in the forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma","volume":"11","author":"Rice","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib80","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.lungcan.2020.12.003","article-title":"CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma","volume":"152","author":"Berger","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.athoracsur.2019.07.097","article-title":"Posterior intercostal lymph nodes double recurrence and death risk in malignant pleural mesothelioma","volume":"110","author":"Friedberg","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib82","first-page":"523","article-title":"Extrapleural pneumonectomy and extended pleurectomy\/decortication for malignant pleural mesothelioma: the Memorial Sloan-Kettering Cancer Center approach","volume":"1","author":"Rusch","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib83","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.3390\/jcm11154537","article-title":"Single-center 20-year experience in surgical treatment of malignant pleural mesothelioma","volume":"11","author":"Mangiameli","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib84","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jtho.2023.06.011","article-title":"European epidemiology of pleural mesothelioma-real-life data from a joint analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database","volume":"18","author":"Opitz","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib85","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jtho.2017.02.026","article-title":"Improved outcomes with modern lung-sparing trimodality therapy in patients with malignant pleural mesothelioma","volume":"12","author":"Shaikh","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib86","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01243894-200602000-00014","article-title":"Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma","volume":"1","author":"Sugarbaker","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib87","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1016\/j.jtcvs.2017.12.131","article-title":"Macroscopic complete resection is not associated with improved survival in patients with malignant pleural mesothelioma","volume":"155","author":"Batirel","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib88","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.asjsur.2024.11.099","article-title":"Comparison of surgical treatment and systemic chemotherapy in patients with non-epithelioid malignant pleural mesothelioma","volume":"48","author":"Arak","year":"2025","journal-title":"Asian J Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib89","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/ejcts\/ezw045","article-title":"The management of the diaphragm during radical surgery for malignant pleural mesothelioma","volume":"50","author":"Sharkey","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib90","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jtho.2019.04.029","article-title":"A proposed system toward standardizing surgical-based treatments for malignant pleural mesothelioma, from the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce","volume":"14","author":"Friedberg","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib91","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","article-title":"Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the International Association for the Study of Lung Cancer International Staging Committee and the international mesothelioma interest","volume":"6","author":"Rice","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib92","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.amjsurg.2018.06.008","article-title":"Synoptic operative reporting for laparoscopic cholecystectomy and pancreaticoduodenectomy: a multi institutional pilot study evaluating completeness and surgeon perceptions","volume":"216","author":"Deal","year":"2018","journal-title":"Am J Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib93","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1245\/s10434-022-11375-w","article-title":"Technical standards for cancer surgery: Commission on Cancer Standards 5.3-5.8","volume":"29","author":"Katz","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib94","series-title":"AJCC Cancer Staging System: Diffuse Pleural Mesothelioma","year":"2024"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib95","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jtcvs.2005.11.044","article-title":"The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma","volume":"131","author":"Edwards","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib96","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3892\/or.2013.2800","article-title":"Lymph node involvement and metastatic lymph node ratio influence the survival of malignant pleural mesothelioma: a French multicenter retrospective study","volume":"31","author":"Hysi","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib97","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1016\/j.cllc.2018.08.007","article-title":"Survival by histologic subtype of malignant pleural mesothelioma and the impact of surgical resection on overall survival","volume":"19","author":"Verma","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib98","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/SLA.0000000000000903","article-title":"Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients","volume":"260","author":"Sugarbaker","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib99","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1200\/JCO.1994.12.6.1156","article-title":"A phase II trial of pleurectomy\/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma","volume":"12","author":"Rusch","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0003-4975(96)01228-3","article-title":"Patterns of failure after trimodality therapy for malignant pleural mesothelioma","volume":"63","author":"Baldini","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib101","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.athoracsur.2021.04.078","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication for malignant pleural mesothelioma","volume":"113","author":"Zhou","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib102","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.2005.04.6813","article-title":"Phase I to II study of pleurectomy\/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma","volume":"24","author":"Richards","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib103","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jtcvs.2014.10.041","article-title":"Pleurectomy\/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience","volume":"149","author":"Lang-Lazdunski","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib104","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/BF02303746","article-title":"Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma","volume":"4","author":"Pass","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib105","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/SLA.0000000000004306","article-title":"Pleurectomy decortication in the treatment of malignant pleural mesothelioma: encouraging results and novel prognostic implications based on experience in 355 consecutive patients","volume":"275","author":"Lapidot","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib106","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jtcvs.2013.07.012","article-title":"Clinical indications and results after chest wall resection for recurrent mesothelioma","volume":"146","author":"Burt","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib107","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.athoracsur.2019.11.048","article-title":"Clinical outcomes with recurrence after pleurectomy\/decortication for malignant pleural mesothelioma","volume":"109","author":"Nakamura","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib108","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.athoracsur.2009.09.028","article-title":"Second surgery for recurrence of malignant pleural mesothelioma after extrapleural pneumonectomy","volume":"89","author":"Politi","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib109","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2020.11.022","article-title":"Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma","volume":"152","author":"Ghirardelli","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib111","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.lungcan.2021.02.033","article-title":"Managing oligoprogressive malignant pleural mesothelioma with stereotactic body radiation therapy","volume":"157","author":"Barsky","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110057","article-title":"Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma","volume":"191","author":"Shin","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib113","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/j.cllc.2018.04.019","article-title":"Utilization of intensity-modulated radiation therapy for malignant pleural mesothelioma in the United States","volume":"19","author":"Shaaban","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib114","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.prro.2020.02.007","article-title":"Disease-related outcomes and toxicities of intensity modulated radiation therapy after lung-sparing pleurectomy for malignant pleural mesothelioma: a systematic review","volume":"10","author":"Patel","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.prro.2020.05.004","article-title":"Consensus statement on proton therapy in mesothelioma","volume":"11","author":"Zeng","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib116","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/php.13065","article-title":"A novel prospective study assessing the combination of photodynamic therapy and proton radiation therapy: safety and outcomes when treating malignant pleural mesothelioma","volume":"95","author":"Rice","year":"2019","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib117","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jtho.2019.03.030","volume":"14","author":"Gomez","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib118","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.lungcan.2019.03.023","article-title":"The role of radiation treatment in pleural mesothelioma: highlights of the 14th International Conference of the International Mesothelioma Interest Group","volume":"132","author":"MacRae","year":"2019","journal-title":"Lung Cancer"},{"issue":"suppl 21","key":"10.1016\/j.athoracsur.2026.03.074_bib119","doi-asserted-by":"crossref","first-page":"S2565","DOI":"10.21037\/jtd.2018.07.65","article-title":"Adjuvant, neoadjuvant, and definitive radiation therapy for malignant pleural mesothelioma","volume":"10","author":"Cramer","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.21037\/tlcr.2017.04.01","article-title":"2nd. Immunotherapy and radiation therapy for malignant pleural mesothelioma","volume":"6","author":"Alley","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.athoracsur.2026.03.074_bib121","article-title":"First-ever abscopal effect after palliative radiotherapy and immuno-gene therapy for malignant pleural mesothelioma","volume":"11","author":"Barsky","year":"2019","journal-title":"Cureus"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497526003450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497526003450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:00:56Z","timestamp":1782122456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497526003450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0003497526003450"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2026.03.074","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2026.03.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}